Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Questerre Reports Voting Results of Shareholders’ Meeting

2018-07-08 globenewswire
THIS NEWS RELEASE IS NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA TO UNITED STATES NEWSWIRE SERVICES OR UNITED STATES PERSONS
QEC QTEYF

4
Questerre finalizes feasibility study for Jordan oil shale project

2018-06-27 globenewswire
THIS NEWS RELEASE IS NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA TO UNITED STATES NEWSWIRE SERVICES OR UNITED STATES PERSONS
QEC MALRY MALRF MIN QTEYF

0
NORWEGIAN STOCKS-Questerre drops almost 50 pct on possible Quebec ban

2018-06-07 reuters
OSLO, June 7 (Reuters) - * Norwegian shares traded up on Thursday * Oslo’s benchmark index rose 0.98 pct, or 8.63 points, to 891.61 points and was up by 8.42 pct year-to-date * The broader Oslo All Share Index was up 0.98 percent * Brent crude futures, a trigger for the oil heavy Oslo Bourse, rose $1.17 to $76.53 a barrel * Oil rises as reality dawns over Venezuela’s export crisis * Among the biggest firms on the Oslo Bourse, Equinor rose 1.
YRAIF QEC YARIY XXLLY QTEYF

1
Questerre condemns short term election politics in Quebec

2018-06-06 globenewswire
THIS NEWS RELEASE IS NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA TO UNITED STATES NEWSWIRE SERVICES OR UNITED STATES PERSONS
QEC QBC QTEYF

0
NORWEGIAN STOCKS-Oslo hit by lower oil price, Norwegian Air weak before May traffic

2018-06-05 reuters
OSLO, June 5 (Reuters) - * Norwegian shares traded down on Tuesday * Oslo’s benchmark index fell -0.30 pct, or -2.65 points, to 879.44 points and was up by 8.30 pct year-to-date * The broader Oslo All Share Index was down 0.5 percent * Brent crude futures, a trigger for the oil heavy Oslo Bourse, fell $-1.01 to $74.28 a barrel * Among the biggest firms on the Oslo Bourse, Equinor fell 1.26 pct, Telenor rose 0.
GOGL QEC QTEYF

0
Questerre updates litigation for Quebec assets; announces spud of Kakwa North well

2018-06-04 globenewswire
CALGARY, Alberta, June 04, 2018 (GLOBE NEWSWIRE) -- Questerre Energy Corporation (“Questerre” or the “Company”) (TSX:QEC) (OSE:QEC) reported on the status of legal proceedings related to its assets in Quebec.
QEC QTEYF

0
Questerre settles lawsuit and consolidates Quebec position

2018-06-04 globenewswire
THIS NEWS RELEASE IS NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA TO UNITED STATES NEWSWIRE SERVICES OR UNITED STATES PERSONS
QEC QTEYF

67
Unknown, Profitable, Oil-Weighted Energy Producer At Deep Discount To NAV And Peers

2018-05-23 seekingalpha
Razor Energy is an oil-weighted energy producer that has increased its production significantly since 2017 while maintaining a strong balance sheet with leverage being well below 2 times.
BTE PGH CJ CRLFF CPG WCP YGR BNEFF VET SGY ZPTAF RRENF YGRAF RRX QTEYF GXOCF QEC TNEYF GENGF ATU CPG BNE RZREF GXO VET IPOOF GXE BTE SPGYF

0
Questerre reports first quarter 2018 results

2018-05-11 globenewswire
CALGARY, Alberta, May 11, 2018 (GLOBE NEWSWIRE) -- Questerre Energy Corporation (“Questerre” or the “Company”) (TSX:QEC) (OSE:QEC) reported today on its financial and operating results for the first quarter ended March 31, 2018.
QEC QTEYF

0
Questerre engages Hatch for engineering on Jordan oil shale project

2018-04-06 globenewswire
THIS NEWS RELEASE IS NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA TO UNITED STATES NEWSWIRE SERVICES OR UNITED STATES PERSONS
QEC QTEYF

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...